Author: Lisa Williamson
Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!
Matthew Boudreau, a chemistry PhD candidate in the CCIL Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant from the National Cancer Institute (NCI). Boudreau’s research has centered around a novel therapeutic, ERSO, that successfully eradicates
Congratulations to Dr. Steven Motika for being awarded a postdoctoral fellowship from the NIH!
A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer
Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a novel small molecule compound that is now the subject of a new global licensing agreement between the pharmaceutical company Bayer
Congratulations to Riley Svec
Riley Svec was awarded a position on the NIH Chemistry-Biology Interface Training Grant. He was an Advanced Graduate Student speaker at the 15th Annual Symposium on Friday, October 4, 2019.
Congratulations to Kristen Muñoz for being awarded a position on the NIH Chemistry-Biology Interface Training Grant!
Gram-negative bacteria have emerged that are resistant to most antibiotics, a troubling trend since a new class of antibiotics for Gram-negative pathogens has not been introduced in the clinic in 50 years. Central to the issue with discovering novel antibiotics
Congratulations to former graduate student Dr. Michelle Richter
Dr. Richter received the ACS Scarborough Award for Graduate Excellence in Medicinal Chemistry! See mention of Michelle in Boston Globe story.
Congratulations to two students for receiving NSF Research Fellowships
We congratulate graduate student Martin Garcia Chavez and undergraduate Amanda Cowfer for being awarded NSF Research Fellowships!
Congratulations to Dr. Andrew Riley
Dr. Riley was awarded an F32 postdoctoral fellowship from the NIH!
See story on Pretzel, a pet dog with glioma successfully treated with PAC-1.
Clinical trials on companion animals diagnosed with cancer have brought new hope to their owners—and new data for a cutting-edge cancer drug being developed by scientists at Illinois.
By Mary Timmins
On the day we meet Pretzel, the weather is